Analyze Diet
Drug testing and analysis2017; 9(9); 1363-1371; doi: 10.1002/dta.2205

Doping control study of AICAR in post-race urine and plasma samples from horses.

Abstract: Acadesine, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, commonly known as AICAR, is a naturally occurring adenosine monophosphate-activated protein kinase (AMPK) activator in many mammals, including humans and horses. AICAR has attracted considerable attention recently in the field of doping control because of a study showing the enhancement of endurance performance in unexercised or untrained mice, resulting in the term 'exercise pill'. Its use has been classified as gene doping by the World Anti-Doping Agency (WADA), and since it is endogenous, it may only be possible to control deliberate administration of AICAR to racehorses after establishment of an appropriate threshold. Herein we report our studies of AICAR in post-race equine urine and plasma samples including statistical studies of AICAR concentrations determined from 1,470 urine samples collected from thoroughbreds and standardbreds and analyzed in Australia, France, and Hong Kong. Quantification methods in equine urine and plasma using liquid chromatography-mass spectrometry were developed by the laboratories in each country. An exchange of spiked urine and plasma samples between the three countries was conducted, confirming no significant differences in the methods. However, the concentration of AICAR in plasma was found to increase upon haemolysis of whole blood samples, impeding the establishment of a suitable threshold in equine plasma. A possible urine screening cut-off at 600 ng/mL for the control of AICAR in racehorses could be considered for adoption. Application of the proposed screening cut-off to urine samples collected after intravenous administration of a small dose (2 g) of AICAR to a mare yielded a short detection time of approximately 4.5 h. Copyright © 2017 John Wiley & Sons, Ltd.
Publication Date: 2017-05-31 PubMed ID: 28407446DOI: 10.1002/dta.2205Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study focuses on controlling the deliberate use of AICAR, a natural AMPK activator, in racehorses. The researchers conducted tests on post-race equine urine and plasma samples from different countries and proposed a screening cut-off in the urine to detect AICAR.

Objective of the Study

  • The study was primarily focused on controlling the intentional use of AICAR (Acadesine), an activator for adenosine monophosphate-activated protein kinase (AMPK) naturally occurring in mammals like humans and horses. Being classified by the World Anti-Doping Agency (WADA) as gene doping, it has gained attention as it enhances performance endurance, earning it the term ‘exercise pill’.

Methodology

  • Researchers collected and analyzed 1,470 post-race equine urine samples from thoroughbreds and standardbreds in Australia, France, and Hong Kong.
  • They developed quantification methods in equine urine and plasma using liquid chromatography-mass spectrometry.
  • They exchanged spiked urine and plasma samples among the three countries, validating there were no significant differences in the methods.

Findings

  • The research team noted a rise in AICAR concentration in plasma when whole blood samples underwent haemolysis, making it challenging to establish a suitable threshold in horses’ plasma for AICAR detection.
  • They suggested a possible urine screening cut-off for racehorses at 600 ng/mL for AICAR control.
  • The proposed urine screening cut-off was applied to samples obtained post-intravenous administering of a small AICAR dose (2 g) to a mare, which gave a detection period of approximately 4.5 hours.

Significance of the Study

  • The study has significance due to its potential in controlling deliberate AICAR administration in racehorses, as the substance is known to artificially enhance their endurance performance, providing an unfair advantage.
  • The detection protocol for AICAR proposed by the study has importance in the context of regulatory measures for fair participation in equine sports and welfare of the animals.

Cite This Article

APA
Wong JKY, Kwok WH, Chan GHM, Choi TLS, Ho ENM, Jaubert M, Bailly-Chouriberry L, Bonnaire Y, Cawley A, Ming Williams H, Keledjian J, Brooks L, Chambers A, Lin Y, Wan TSM. (2017). Doping control study of AICAR in post-race urine and plasma samples from horses. Drug Test Anal, 9(9), 1363-1371. https://doi.org/10.1002/dta.2205

Publication

ISSN: 1942-7611
NlmUniqueID: 101483449
Country: England
Language: English
Volume: 9
Issue: 9
Pages: 1363-1371

Researcher Affiliations

Wong, Jenny K Y
  • Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T, Hong Kong, China.
Kwok, Wai Him
  • Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T, Hong Kong, China.
Chan, George H M
  • Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T, Hong Kong, China.
Choi, Timmy L S
  • Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T, Hong Kong, China.
Ho, Emmie N M
  • Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T, Hong Kong, China.
Jaubert, Murielle
  • Laboratoire des Courses Hippiques, 15 rue de Paradis, 91370, Verrieres le Buisson, France.
Bailly-Chouriberry, Ludovic
  • Laboratoire des Courses Hippiques, 15 rue de Paradis, 91370, Verrieres le Buisson, France.
Bonnaire, Yves
  • Laboratoire des Courses Hippiques, 15 rue de Paradis, 91370, Verrieres le Buisson, France.
Cawley, Adam
  • Australian Racing Forensic Laboratory, Racing NSW, Sydney, NSW, 2000, Australia.
Ming Williams, H
  • Australian Racing Forensic Laboratory, Racing NSW, Sydney, NSW, 2000, Australia.
Keledjian, John
  • Australian Racing Forensic Laboratory, Racing NSW, Sydney, NSW, 2000, Australia.
Brooks, Lydia
  • Canadian Pari-Mutuel Agency, 1130 Morrison Dr. Suite 101, Ottawa, Ontario, K2H 9N6, Canada.
Chambers, Adam
  • Equine Drug Evaluation Centre, Canadian Pari-Mutuel Agency, 115 Sunnyridge, RR#1, Jerseyville, Ontario, L0R 1R0, Canada.
Lin, Yuanyuan
  • Department of Statistics, The Chinese University of Hong Kong, Sha Tin, N.T, Hong Kong, China.
Wan, Terence S M
  • Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T, Hong Kong, China.

MeSH Terms

  • Aminoimidazole Carboxamide / analogs & derivatives
  • Aminoimidazole Carboxamide / analysis
  • Aminoimidazole Carboxamide / chemistry
  • Aminoimidazole Carboxamide / metabolism
  • Animals
  • Australia
  • Chromatography, Liquid
  • Doping in Sports / prevention & control
  • Horses
  • Humans
  • Ribonucleosides / analysis
  • Ribonucleosides / chemistry
  • Ribonucleosides / metabolism
  • Ribonucleotides / analysis
  • Ribonucleotides / chemistry
  • Ribonucleotides / metabolism
  • Tandem Mass Spectrometry / methods
  • Urinalysis

Citations

This article has been cited 0 times.